Xinmin Liu, MD, PhD, is a Professor and Director of Research Center for Pharmacology and Toxicology at the Institute of Medicinal Plant Development (IMPLAD), Chinese Academy of Medical Sciences (CAMS), Beijing, China. Dr. Liu graduated and earned his medical degree from Hunan Medical College (currently Xiangya School of Medicine, Central South Academy Medical Science (CAMS) & Peking Union Medical College (PUMC) in 1996.
Dr. Liu actively holds and has held leadership positions in many professional organizations. He has been appointed as a member of Expert Advisory Panel on Traditional Medicine of the World Health Organization since 2008. He is also the executive member of Chinese Patent Medicine Branch, Chinese Association of Chinese Medicine, as well as the executive member of Committee of Chinese Material Medica, World Federation of Chinese Medicine Association (WFCMA). He has served as an Expert Advisor to the Evaluation Center for Health Products of Ministry of Health of China. Professor Dr. Liu has been one of the core-experts to draft and design national policies and plans on modernization and internationalization of TCM in the past 10 years, which were organized by the State Administration of Traditional Chinese Medicine of China (SATCM) and Ministry of Science & Technology of China (MOST). He has also been nominated delegate of SATCM to visit Denmark, Pakistan, Peru, and Canada in the international collaborative study on TCM. Dr. Liu currently is a Principal Investigator of several international medicinal plants’ collaborative projects with University of British Columbia, Canada, the Krachi University, Pakistan, and the Centre de Recherche Public de la Sante, Luxembourg, and the Universidad Peruana Cayetano Heredia, Peru.
Dr. Liu has been actively engaged in the field of Neuropharmacology and Neoplastic (Cancer) Pharmacology research on medicinal plants, experimental methodology for Behavioral Neuropharmacology, as well as innovative research strategy for TCM modernization and globalization. Since 1992, Prof. Dr. Liu has been in collaboration with Dr. ShanGuang Chen, the Director of Astronaut Centre of China and adopted an integration of computer, information technology, image processing, data mining, optical sensor technology, chemistry, and molecular biology techniques in behavioral neuropharmacology study on herbal medicines. Dr. Liu has developed a proprietary, automated, large-scale data acquisition and good laboratory practice compliance computer real-time image analyzing systems and comprehensive evaluation scales for animal behavior studies (for example, Step-Through, Water Maze, Step-Down, Shuttle-Box, Swimming and Open Field). The established methodology for behavioral assessment of herbal medicine with improving learning and memory, anti-depression and sedative properties has a great impact in the field of Chinese pharmacology. It was revealed that Kaixin San, Xiaobuxin Tang, Ginseng and Milkwort root have significant effect on improvement of cognitive deficiency associated with depression. More than 20 herbs traditionally used to treat cancer were screened and active ingredients for leukemia and cervical cancer are discovered from Indian Mock-strawberry herb. These findings and achievements were awarded 2nd and 3rd Science and Technology Prizes from Ministry of Health, and Ministry of Science & Technology of China (MOST) as well as Commission of Science, Technology, and Industry for National Defense (COSTIND).
He has been awarded more than 20 R & D herbal research grants from Chinese government agencies in the past 20 years. Throughout his career, Dr. Liu has received over 10 academic awards from MOST, SATCM, as well as Ministry of Health of China. Dr. Liu has published widely, authoring, or coauthoring more than 50 publications, including journal articles and book chapters on medicinal plants and pharmacology.
As Professor of Pharmacology, Dr. Liu has been the supervisor and/or mentor for post-doctoral fellows, Ph.D. candidates and graduate students at Chinese Academy Medical Science (CAMS) & Peking Union Medical College (PUMC) since 2003. 6 Ph.D. graduates and 4 Master graduates have successfully completed their graduate program under the guidance of Professor Liu. Prof. Liu also supervised 4 international master’s students, in collaboration with their guidance committee, from the Krachi University, Pakistan, and the Universidad Peruana Cayetano Heredia, Peru.
Dr. Liu serves on several journal editorials and advisory boards including, in addition to the International Journal of Integrative Oncology, the journal Chinese Traditional and Herbal Drugs, Chinese Journal of Comparative Medicine, and Journal of Basic Science and Engineering.